Molecular Partners AG (MOLN)
5.08
-0.14
(-2.68%)
USD |
NASDAQ |
Dec 20, 16:00
5.18
+0.10
(+1.97%)
After-Hours: 20:00
Molecular Partners Profit Margin (Quarterly): -2.41K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AC Immune SA | 21.59% |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | -2.84K% |
| NLS Pharmaceutics Ltd | -- |
| MoonLake Immunotherapeutics | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.35% |
| Return on Assets | -33.67% |
| Return on Invested Capital | -37.35% |
| Operating Margin (Quarterly) | -2.14K% |
| Return on Net Operating Assets | -271.0% |